Polymorphism of Insulin-like Growth Factor I Gene and Bone Mineral Density

[1]  M. Bostrom,et al.  Bone growth factors. , 2000, The Orthopedic clinics of North America.

[2]  Y. Ouchi,et al.  Association of Bone Mineral Density with Apolipoprotein E Phenotype , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  G. Cooper,et al.  Are vitamin D receptor polymorphisms associated with bone mineral density? A meta‐analysis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  C. Coupland,et al.  Body Size Accounts for Most Differences in Bone Density Between Asian and Caucasian Women , 1996, Calcified Tissue International.

[5]  J. Eisman,et al.  Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Delmas,et al.  Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Y. Ouchi,et al.  Association of bone mineral density with polymorphism of the estrogen receptor gene , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Y. Ouchi,et al.  Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. , 1995, Biochemical and biophysical research communications.

[9]  I. Kanazawa,et al.  Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease , 1995, Nature Genetics.

[10]  J. Veldhuis,et al.  Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. , 1995, The Journal of clinical endocrinology and metabolism.

[11]  J. Eisman,et al.  The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  V. Han,et al.  Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. , 1995, Bone.

[13]  H. Melhus,et al.  Vitamin D receptor genotypes in osteoporosis , 1994, The Lancet.

[14]  S. Inzucchi,et al.  Clinical review 61: Effects of growth hormone on human bone biology. , 1994, The Journal of clinical endocrinology and metabolism.

[15]  T. Yoshikawa,et al.  Do variations in hip geometry explain differences in hip fracture risk between japanese and white americans? , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[17]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[18]  M. Ranke,et al.  Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis , 1993, Journal of internal medicine.

[19]  J. Eisman,et al.  Changes in axial bone density with age: A twin study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  B. Dawson-Hughes,et al.  Heritable and life‐style determinants of bone mineral density , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  J. Tobias,et al.  Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats. , 1992, Endocrinology.

[22]  G. Rodan,et al.  Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. , 1991, Molecular endocrinology.

[23]  C. Slemenda,et al.  Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  S. Duursma,et al.  The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? , 1990, The Journal of endocrinology.

[25]  A. Moses,et al.  Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat. , 1989, Endocrinology.

[26]  Y. Nishizawa,et al.  Quantification of bone mineral content using dual‐photon absorptiometry in a normal Japanese population , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  J. Hopper,et al.  Reduced bone mass in daughters of women with osteoporosis. , 1989, The New England journal of medicine.

[28]  E. Canalis,et al.  Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. , 1989, Endocrinology.

[29]  S. Mohan,et al.  Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. , 1989, Biochemical and biophysical research communications.

[30]  L. Raisz,et al.  Local and systemic factors in the pathogenesis of osteoporosis. , 1988, World review of nutrition and dietetics.

[31]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[32]  J. Hopper,et al.  Genetic determinants of bone mass in adults. A twin study. , 1987, The Journal of clinical investigation.

[33]  S. M. Russell,et al.  Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Lutz.  Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs. , 1986, The American journal of clinical nutrition.

[35]  D. K. Didier,et al.  Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. , 1986, The Journal of biological chemistry.

[36]  R L Hintz,et al.  Insulin-like growth factors I and II: aging and bone density in women. , 1984, The Journal of clinical endocrinology and metabolism.

[37]  M. Kutner,et al.  Impaired growth hormone secretion in the adult population: relation to age and adiposity. , 1981, The Journal of clinical investigation.

[38]  J. Price.  Human polymorphism. , 1967, Journal of medical genetics.

[39]  Ames,et al.  Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. , 1997, The New England journal of medicine.

[40]  A. Asaka,et al.  VITAMIN D RECEPTOR GENE POLYMORPHISM AND BONE MINERAL DENSITY IN HEALTH JAPANESE WOMEN , 1994 .

[41]  S. Miller,et al.  Insulin-like growth factor I gene expression in isolated rat renal collecting duct is stimulated by epidermal growth factor. , 1991, The Journal of clinical investigation.

[42]  G. Howard,et al.  In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. , 1991, Bone.

[43]  V. Mitev,et al.  [Insulin-like growth factors]. , 1990, Eksperimentalna meditsina i morfologiia.

[44]  E. Canalis,et al.  Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. , 1988, Endocrinology.

[45]  P. Geusens,et al.  Genetic determinants of bone mineral content at the spine and radius: a twin study. , 1987, Bone.